<?xml version="1.0" encoding="UTF-8"?>
<p id="par0325">Besides gene editing techniques, the expression of CCR5 can be artificially modulated through the use of pharmacological antagonists (
 <italic>e.g.</italic> maraviroc), chemokine ligands, and monoclonal antibodies (
 <xref rid="bib0460" ref-type="bibr">Fantuzzi et al., 2019</xref>). The use of CCR5 antagonists is well established for the treatment of HIV infection and is currently being tested for the treatment of many other diseases, such as cancer (
 <xref rid="bib1135" ref-type="bibr">Pervaiz et al., 2019</xref>; 
 <xref rid="bib0655" ref-type="bibr">Huang et al., 2020a</xref>), stroke (
 <xref rid="bib0695" ref-type="bibr">Joy et al., 2019</xref>), and cocaine addiction-related disorders (
 <xref rid="bib0615" ref-type="bibr">Hall et al., 2020</xref>; 
 <xref rid="bib1085" ref-type="bibr">Nayak et al., 2020</xref>).
</p>
